3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Leukemia, Biphenotypic, Acute
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Ganglioneuroblastoma
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Recurrence
1
Neuroblastoma
1
Medulloblastoma
1
Lymphoma
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
Leukemia, Mast-Cell
1
Leukemia, Large Granular Lymphocytic
1
Leukemia
1
Graft vs Host Disease
1
GATA2 Deficiency
1
Burkitt Lymphoma
1
Blast Crisis
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Specimen Handling
4
Biopsy
4
Whole-Body Irradiation
3
Mycophenolic Acid
3
Cyclosporine
3
Cyclophosphamide
3
fludarabine phosphate
2
decitabine and cedazuridine drug combination
2
Sirolimus
2
Melphalan
2
Granulocyte Colony-Stimulating Factor
2
Busulfan
2
venetoclax
1
tocilizumab
1
ruxolitinib
1
peginterferon alfa-2b
1
iadademstat
1
fludarabine
1
Tacrolimus
1
Rituximab
1
Peripheral Blood Stem Cell Transplantation
1
Methotrexate
1
Idarubicin
1
Hyperbaric Oxygenation
1
Filgrastim
1
Etoposide
1
Cytarabine
1
Cyclosporins
1
Cord Blood Stem Cell Transplantation
1
Clofarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic-Myeloproliferative Diseases
×
Thiotepa
×
30 days
×
Clear all
No trials found.